Detalles de la búsqueda
1.
Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWP.
Am J Hematol
; 94(8): 880-890, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31095771
2.
Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trial.
Br J Haematol
; 180(1): 82-89, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29193007
3.
Monitoring of hematopoietic chimerism after transplantation for pediatric myelodysplastic syndrome: real-time or conventional short tandem repeat PCR in peripheral blood or bone marrow?
Biol Blood Marrow Transplant
; 20(12): 1918-25, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25087899
4.
Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation.
Blood
; 118(20): 5681-8, 2011 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-21948300
5.
Impaired IL-23-dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency.
J Exp Med
; 219(10)2022 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36094518
6.
Transplant center practices for psychosocial assessment and management of pediatric hematopoietic stem cell donors.
Bone Marrow Transplant
; 54(11): 1780-1788, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30971776
7.
More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling.
Blood Adv
; 3(21): 3393-3405, 2019 11 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31714961
8.
Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial.
J Clin Oncol
; 33(11): 1275-84, 2015 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25605857
9.
SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy.
Front Pediatr
; 2: 75, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25101252
10.
Epidemiological perspectives on type 1 diabetes in childhood and adolescence in germany: 20 years of the Baden-württemberg Diabetes Incidence Registry (DIARY).
Diabetes Care
; 33(2): 338-40, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19903753
Resultados
1 -
10
de 10
1
Próxima >
>>